Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $8.4700 (-4.08%) ($8.4700 - $8.4700) on Mon. Dec. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 42 | Latest Price | $8.4700(-4.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -6.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -5.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(13%) SKYY(13%) ARKG(12%) BLOK(12%) BNDX(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.335% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) UNG(-6%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.56(-177.45%) | Inflection Point | Yes | Resistance Level | $10.18 | 5 Day Moving Average | $9.13(-7.23%) | 10 Day Moving Average | $9.81(-13.66%) | 20 Day Moving Average | $10.18(-16.8%) | To recent high | -40.7% | To recent low | 0% | Market Cap | $443m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |